KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Current Deferred Tax Assets: 2009-2015

  • Teva Pharmaceutical Industries' Current Deferred Tax Assets fell 25.98% to $735.0 million in Q4 2015 from the same period last year, while for Dec 2015 it was $735.0 million, marking a year-over-year decrease of 25.98%. This contributed to the annual value of $735.0 million for FY2015, which is 25.98% down from last year.
  • According to the latest figures from Q4 2015, Teva Pharmaceutical Industries' Current Deferred Tax Assets is $735.0 million, which was down 25.98% from $993.0 million recorded in Q4 2014.
  • Teva Pharmaceutical Industries' Current Deferred Tax Assets' 5-year high stood at $1.1 billion during Q4 2012, with a 5-year trough of $735.0 million in Q4 2015.
  • Its 3-year average for Current Deferred Tax Assets is $937.3 million, with a median of $993.0 million in 2014.
  • Its Current Deferred Tax Assets has fluctuated over the past 5 years, first crashed by 33.47% in 2011, then climbed by 18.22% in 2012.
  • Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Current Deferred Tax Assets stood at $966.0 million in 2011, then grew by 18.22% to $1.1 billion in 2012, then declined by 5.08% to $1.1 billion in 2013, then fell by 8.39% to $993.0 million in 2014, then fell by 25.98% to $735.0 million in 2015.
  • Its Current Deferred Tax Assets was $735.0 million in Q4 2015, compared to $993.0 million in Q4 2014 and $1.1 billion in Q4 2013.